MarkSSolowayMD

PubMed

• 211 citations
  A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
  Maurizio Brausi, J. Alfred Witjes, Donald L. Lamm, Raj Persad, Joan Palou
  The Journal of Urology. 2011-12-01
• 57 citations
  Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients.
  Rajinikanth Ayyathurai, Murugesan Manoharan, Alan M. Nieder, Bruce R. Kava, Mark S. Soloway
  BJU International. 2008-04-01
• 23 citations
  Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
  Madhusudan P. Koya, Murugesan Manoharan, Sandy S. Kim, Mark S. Soloway
  BJU International. 2005-11-01

Journal Articles

• The effect of hyperventilation on subsequent cerebral infarction  
  Soloway MS, Nadel W, Albin MS, White RJ, Anesthesiology, 29(5):975-980
• Delayed hyperventilation in the treatment of experimental cerebral vascular occlusion.  
  Soloway MS, Moriarty G, White RJ, Surg Forum, 21:423-425
• The effect of delayed hyperventilation and experimental middle cerebral occlusion.  
  Soloway MS, Moriarty G, Fraser JG, White RJ, Neurology, 20(4):417
• Takayasu's arteritis. Report of a case with unusual findings.  
  Soloway MS, Moir TW, Linton DS, Jr, Am J Cardiol, 25(2):258-263
• Effect of delayed hyperventilation on experimental cerebral infarction.  
  Soloway MS, Moriarty G, Fraser JG, White RJ, Neurology, 21(5):479-485
• Cytology of ileal conduit urine.  
  Malmgren RA, Soloway MS, Chu EW, Del Vecchio PR, Ketcham AS, Acta Cytol, 15(5):506-509
• Value of renography following radical pelvic cancer surgery.  
  Soloway MS, Larson SM, Myers GH, Jr., Johnston GS, Ketcham AS, J Surg Oncol, 4(4):306-319
• Effect of regional lymphadenectomy on development of concomitant immunity.  
  Soloway MS, Pendergrast WJ, Myers GH, Jr, Surg Forum, 23(0):101-102
• Radioisotope renography in patients with an ileal conduit: the importance of the sitting position.  
  Soloway MS, Myers GH, Jr., Larsen S, Johnston G, J Urol, 108(2):202-204
• Ileal conduit exfoliative cytology in the diagnosis of recurrent cancer.  
  Soloway MS, Myers GH, Jr., Burdick JF, Malmgren RA, J Urol, 107(5):835-839
• Evidence against a vesicorenal reflux.  
  Soloway MS, Larson SM, Myers GH, Jr, J Urol, 107(5):751-754
• Blood borne metastases to the kidney. Angiographic investigation of three vascular tumors.  
  Shimkin PM, Buchignani JS, Soloway MS, Acta Radiol Diagn (Stockh), 12(3):387-395
• Metastatic melanoma of the gallbladder.  
  Shimkin PM, Soloway MS, Jaffe E, Am J Roentgenol Radium Ther Nucl Med, 116(2):393-395
• Renography in the evaluation of patients with ileal conduits.  
  Soloway MS, Myers GH, Jr., Johnston G, Ketcham AS, Surg Gynecol Obstet, 135(4):521-524
• Effect of chemotherapeutic agents on bladder cancer: a new animal model.  
  Soloway MS, deKernion JB, Rose D, Persky L, Surg Forum, 24:542-544
• Evaluation of urinary cytology as an indicator of bladder neoplasia in mice.  
  Soloway MS, Myers GH, Jr., Marrone JA, Del Vecchio PR, Malmgren RA, J Urol, 109(2):249-252
• The effect of hormonal therapy on a transplantable renal cortical adenocarcinoma in syngeneic mice.  
  Soloway MS, Myers GH, Jr, J Urol, 109(3):356-361
• Urothelial susceptibility to neoplastic cellular implantation.  
  Weldon TE, Soloway MS, Persky L, Surg Forum, 25(0):547-549
• Chemotherapy of experimental transitional-cell carcinoma.  
  Dekernion JB, Soloway MS, Persky L, Urology, 4(1):63-68
• Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression.  
  Soloway MS, Myers GH, Jr., Krueger G, Urology, 3(4):437-443
• Failure of ascorbic acid to inhibit FANFT-induced bladder cancer.  
  Soloway MS, Cohen SM, Dekernion JB, Persky L, J Urol, 113(4):483-486
• Single and combination chemotherapy for primary murine bladder cancer.  
  Soloway MS, Cancer, 36(2):333-340
• Susceptibility of urothelium to neoplastic cellular implantation.  
  Weldon TE, Soloway MS, Urology, 5(6):824-827
• Fournier's syndrome: synergistic gangrene of the scrotum.  
  Rudolph R, Soloway MS, DePalma RG, Persky L, Am J Surg, 129(5):591-596
• Case profile: Horseshoe kidney with calculi in patient with sarcoidosis.  
  Soloway MS, Herman G, Guerrier K, Persky L, Urology, 8(6):608-609
• Join now to see all

Books/Book Chapters

• Actual Strategies for the Future of Uro-Oncology. 
  Chapter: Incidence, Etiology, Location, Prevention and Treatment of Positive Surgical Margins After Radical Prostatectomy for Prostate Cancer 
  Weider, J.A. and Soloway MSEditors: H. Villavicencio and E. Solsona.
• Scientific Foundations of Urology. 
  Chapter: Animal models in bladder cancer research 
  Page 567 - 575Soloway MS and Hardeman, S.WEditors: Chisholm, G.D. and Fair, W.R.Yearbook Medical Publishers, Chicago
• Prostate Cancer and Testicular Cancer. 
  Chapter: Morbidity of modified pelvic lymphoidectomy and external beam radiation therapy for prostatic cancer 
  Page 145 - 149Brausi, M. and Soloway MSEditors: Donald W. Newling and William G. Jones.Wiley-Lass, Inc, New York
• Aktuelle Therapie des prostatakarzinoms. 
  Chapter: Studien der National Prostatic Cancer Project and Treatment Group des fortgeschrittenen prostatakarzinoms 
  Page 361 - 369Soloway MSEditors: R. Ackermann, J. Altwein.Springer-Verlag, Berlin
• Problems in Urology. Transitional Cell Malignancy. 
  Chapter: Transitional cell carcinoma of the prostate: diagnosis, staging and management 
  Page 554 - 563Matzkin, H., and Soloway MSEditors: Soloway MS.J.B. Lippincott Co, Philadelphia, PA
• Urology Clinics of North America. 
  Chapter: Management of ureteral and renal pelvic recurrence after cystectomy 
  Page 653 - 660Braslis, K.G. and Soloway MSW. B. Saunders Company, Philadelphia, PA
• Practical Cases in Urology. 
  Chapter: Bladder Cancer Treatment Stage by Stage 
  Braslis, K. and Soloway MSEditors: Alan J. Wein, M.D.
• Advances in Urology, Vol. 9. 
  Chapter: Video Resection Techniques in the Diagnosis and Management of Bladder Tumors 
  Page 11 - 23Dudak, S.D. and Soloway MSEditors: EJ McGuire, D. Bloom, WJ Catalona and LI Lipshultz.Mosby-Year Book
• Hematology/Oncology Clinics of North America, Vol. 10. 
  Chapter: Is there a role for induction androgen deprivation prior to radical prostatectomy? 
  Page 627 - 641Watson, R.and Soloway MS
• Urology Highlights. 
  Chapter: Bladder Cancer 
  Soloway MSEditors: J. Shah.Health Press, Oxford
• Advances in Urology, vol 10:373-396. 
  Chapter: Neoadjuvant hormonal therapy for prostate cancer 
  Öbek, C., Watson, R.B. and Soloway MSMosby-Year Book, Inc
• Urologic Oncology. 
  Chapter: Superficial transitional cell carcinoma of the bladder: Management and prognosis 
  Page 256 - 274Korman, H.J., Watson, R.W. and Soloway MSEditors: Joseph E. Oesterling and Jerome P. Richie, M.D.M.W. Saunders Co, Philadelphia, PA
• Lower Genitourinary Tract Radiology, Diagnostic and Therapeutic. 
  Chapter: Bladder cancer: Clinical aspects and management 
  Page 129 - 137Watson, Roger B., Korman, Howard J. and Soloway, Mark., SEditors: S. Z. H. Jafri, Ananias Diokno and Marco Amendola.Springer Verlag, New York, NY
• Atlas of Urologic Clinics of North America. 
  Chapter: Transurethral resection of bladder cancer: The mainstay of treatment 
  Page 1 - 14Shelfo, S.W., Brady, J.D. and Soloway MS
• Progress in Clinical and Biological Research, Volume 303; Therapeutic Progress in Urological Cancers. 
  Chapter: Should all superficial bladder tumors be treated with intravesical therapy 
  Page 491 - 501Soloway MSEditors: Murphy, G.P. and Khoury, S.Alan R. Liss, Inc, New York
• Medicine Publishing Foundation Symposium Series 37. 
  Chapter: Optimal Therapy for Patients with High Risk Superficial Bladder Cancer-Controversy and Consensus 
  Page 31 - 36Soloway MSEditors: Bouhle A. and Jochan D.The Medicine Group Ltd, Oxford
• Isis Medical media. 
  Chapter: Controversies in the management of clinically localized prostate cancer in new perspectives in prostate cancer 
  Page 205 - 210Soloway MSEditors: A. Bellegrun, Roger S. Kirby and T.T.D. Oliver.Oxford, England
• Prostatic Diseases. 
  Chapter: Management of loco-regionally advanced (stage T3) prostate cancer 
  Page 488 - 495Shelfo S.W. and Soloway MSEditors: H. Lepor. W. B.Saunders Company
• Current Clinical Urology: Bladder Cancer; Current Diagnosis and Treatment. 
  Chapter: Intravesical chemotherapy in the treatment of superficial bladder cancer 
  Page 183 - 223Bird V.G., Soloway MS and Malmstromp UEditors: M. J. Droller.Humana Press
• Renal, Bladder, Prostate and Testicular Cancer. An update. 
  Chapter: The approach to high grade transitional cell carcinoma in Ta, CIS and T1 stages 
  Page 265 - 272Soloway MS and Sofer, MEditors: Carl H. Kurth, Gerald H. Mickisch and Fritz H. Schroeder.The Parthenon Publishing Group
• Prostate Cancer: Principles and Practice. 
  Chapter: Contemporary Modifications to Open Retropubic Radical Prostatectomy 
  Manoharan M and Soloway MSEditors: Partin A, Parsons K, and Kirby R.
• Textbook of Bladder Cancer. 
  Chapter: Cystoscopy 
  Page 179 - 185Nieder AM, Soloway MSEditors: Lerner SP, Schoenberg MP, Sternberg CN.Taylor and Francis, England
• Bladder Tumors, 1st International Consultation on Bladder Tumors. 
  Soloway MS, Carmack A, Khoury SHawaii
• Urology Highlights 2005-06. 
  Chapter: Bladder tumors 
  Page 80 - 86Soloway MSHealth Press
• Thera Strat in Prostate CA. 
  Chapter: Treatment of low risk prostate cancer 
  Kava BR, Nieder AM, Soloway MSEditors: Feneley & Payne H.
• Join now to see all

Abstracts/Posters

• The salutary effect of lower arterial pCO2 in experimental cerebral infarction.
  White, R.J., Soloway MS, Nadel, W., Yashon, D. and Albin, M.S, Fourth International Congress of Neurological Surgery

Lectures

• Gender-Specific Considerations in Healthcare - CME Getaways South Beach 
  CME Getaways, Miami Beach, Florida - 11/30/2012
• The effect of hormonal therapy on a spontaneous murine renal tumor. 
  Annual Meeting of American Association for Cancer Research, Boston, Massachusetts
• The effect of hormonal therapy on the growth of a murine renal cortical adenocarcinoma: a useful experimental model. 
  Annual Meeting of American Urological Association, Washington, D.C
• The effect of chronic immunosuppression on the chemical induction of bladder cancer. 
  Annual Meeting of North Central Section of American Urological Association, Chicago, Illinois
• The effect of regional lymphadenectomy on the development of concomitant immunity. 
  Annual Meeting of American College of Surgeons, San Francisco, California
• Evaluation of urinary cytology as an indicator of bladder neoplasia in mice. 
  Annual Meeting of American Society of Cytologists, New Orleans, Louisiana
• Effect of chemotherapeutic agents on bladder cancer: A new animal model. 
  Multiple Loactions, 1973
• Single and combination chemotherapy for primary murine bladder cancer. 
  Houston, Texas, 1974; Columbus, Ohio, 1974
• Urothelial susceptibility to neoplastic cellular implantation. 
  Annual meeting of American College of Surgeons, Miami, Florida
• A murine model to evaluate intravesical chemotherapy. 
  Annual Meeting of Association for Academic Surgeons, Los Angeles, California
• Urological neoplastic cellular implantation: Intravesical and systemic chemotherapeutic prophylaxis. 
  Annual Meeting of American Association for Cancer Research, San Diego, California
• Urothelial neoplastic cellular implantation: Intravesical and systemic chemotherapeutic prophylaxis. 
  Annual Meeting of American Urological Association, Miami, Florida
• Chemo-immunotherapy of murine bladder cancer. 
  Minneapolis, Minnesota, 1975; Iowa City, Iowa, 1976
• Experimental chemotherapy of murine bladder cancer. 
  U.S.-Japan Cooperative Meeting on Animal Models for Bladder Cancer, Honolulu, Hawaii
• Comparison of thio-tepa and epodyl for intravesical chemotherapy of murine bladder cancer. 
  Southeastern Section American Urological Association Annual Meeting, Hollywood, California
• Combination chemotherapy of advanced bladder and prostate cancer. 
  Southeastern Section American Urological Association Meeting, Hollywood, California
• The effect of long-term chemotherapy and/or BCG on the incidence and growth of murine bladder cancer. 
  American Urological Association Annual Meeting, Las Vegas, Nevada
• Long-term chemotherapy and/or immunotherapy of primary murine bladder cancer. 
  American Association for Cancer Research, Toronto, Canada
• Immunogenicity of murine bladder tumors. 
  Workshop in GU Cancer Immunology, Iowa City, Iowa
• Management of disseminated prostatic cancer chemotherapy. 
  Cancer Update 1976, Methodist Hospital, Memphis, Tennessee
• Intravesical chemotherapy of bladder cancer - a murine model. 
  New York Section American Urological Association, Jerusalem
• Cytoxan, adriamycin and 5-fluorouracil combination chemotherapy of prostate cancer. 
  New York Section American Urological Association, Jerusalem
• Chemotherapy of bladder carcinoma in animal models. 
  National Bladder Cancer Conference, Miami, Florida
• Analysis of serial selected mucosal biopsies of normal appearing urothelium in bladder cancer patients. 
  Southeastern Section American Urological Association, New Orleans, Louisiana
• Immunogenicity of FANFT-induced bladder cancer. 
  Southeastern Section American Urological Association, New Orleans, Louisiana
• Join now to see all

Other

• Optimal management of the T1G3 bladder cancer. 
  Manoharan M, Soloway MS, Urol Clin North Am 2005 May; 32(2):133-45